PARP inhibitors interfere with cancer’s ability to repair damage to its DNA. They are becoming increasingly useful in treating ovarian cancer.
Arelene Weintraub
Advertisement
Articles by Arelene Weintraub
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
From Precision Medicine to AI: The Future of Cancer Care
3
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
4
The Nurse Who Got Me Through CAR-T Cell Therapy for Myeloma
5